Differentiation of Human Dermal Mesenchymal Stem Cells into Cardiomyocytes by Treatment with 5-Azacytidine: Concept for Regenerative Therapy in Myocardial Infarction

<table>Characterization of hDMSCs cell line using molecular markers showing positive expression of CD105, CD73, CD13, CD44, Oct-4, SOX-2, NANOG, LIF, keratin-18, and <i>β</i>-actin.</table>

International Scholarly Research Notices

fig4

Figure 4

Figure 4: Differentiation of Human Dermal Mesenchymal Stem Cells into Cardiomyocytes by Treatment with 5-Azacytidine: Concept for Regenerative Therapy in Myocardial Infarction 

Figure 4 | Differentiation of Human Dermal Mesenchymal Stem Cells into Cardiomyocytes by Treatment with 5-Azacytidine: Concept for Regenerative Therapy in Myocardial Infarction 